News Focus
News Focus
Replies to #44519 on Biotech Values
icon url

DewDiligence

04/07/07 9:37 AM

#44520 RE: spartex #44519

>…your statement is somewhat misleading. You forgot to mention that this survey also had 64% who believe DNDN will be approved, or approved with minor conditions such as labeling<

One minus one-third is two-thirds, no? How the heck was the statement in #44507 misleading?